A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies
A Phase Ib/II Clinical Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies
Sponsor: Sumitomo Pharma America, Inc.
Listed as NCT01325441, this PHASE1/PHASE2 trial focuses on Cancer and remains completed. Sponsored by Sumitomo Pharma America, Inc., it has been updated 21 times since 2011, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Study Description(click to expand)This is an open label, multi-center, single arm phase 1 dose escalation study and phase 2 study of BBI608 in combination with paclitaxel in patients with advanced solid tumors for whom weekly paclitaxel is an acceptable option.
This is an open label, multi-center, single arm phase 1 dose escalation study and phase 2 study of BBI608 in combination with paclitaxel in patients with advanced solid tumors for whom weekly paclitaxel is an acceptable option.
Status Flow
Change History
21 versions recorded-
Jan 2026 — Present [monthly]
Completed PHASE1/PHASE2
-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Dec 2023 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Nov 2023 — Dec 2023 [monthly]
Completed PHASE1_PHASE2
▶ Show 16 earlier versions
-
Mar 2023 — Nov 2023 [monthly]
Completed PHASE1_PHASE2
-
May 2022 — Mar 2023 [monthly]
Completed PHASE1_PHASE2
-
Sep 2021 — May 2022 [monthly]
Completed PHASE1_PHASE2
Status: Active Not Recruiting → Completed
-
May 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Feb 2021 — May 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
Status: Recruiting → Active Not Recruiting
-
Aug 2020 — Nov 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2020 — Aug 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Nov 2019 — Feb 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Jul 2019 — Nov 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Apr 2019 — Jul 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Oct 2018 — Apr 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2018 — Oct 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Apr 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sumitomo Pharma America, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .